7. Myocardial revascularisation strategy

PCI versus CABG for treatment of diabetics

FREEDOM Follow-On study
Objective
to report the long-term survival of DM patients with multivessel disease who underwent PCI or CABG
Study
multicentre, randomised trial
Population
Freedom trial 1,900 patients. Of these 943 participated in Freedom follow-up trial
Endpoints
all-cause mortality after median follow-up of 7.5 years
Conclusion
coronary revascularisation with CABG in patients with DM and MVD is associated with long term lower all-cause mortality than PCI
Farkouh et al. J Am Coll Cardiol. 2019;73:629-38
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved